XML 56 R31.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 22 - Valuation and Qualifying Accounts and Reserves
12 Months Ended
Dec. 31, 2014
Valuation and Qualifying Accounts [Abstract]  
Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]
Schedule II

Platform Specialty Products Corporation

Valuation and Qualifying Accounts and Reserves

(in millions)

   
Balance at
beginning of
period
   
Charges to
costs and
expense
   
Deductions
from
reserves
   
Other (2)
   
Balance at
end of period
 
Reserves against accounts receivable (1):
                             
Successor
                             
December 31, 2013 to December 31, 2014
  $ (10.1 )   $ (1.2 )   $ 0.9     $ 0.8     $ (9.6 )
April 23, 2013 (Inception) to December 31, 2013)
    -       (0.3 )     0.6       (10.4 )     (10.1 )
                                         
                                         
Predecessor
                                       
December 31, 2012 to October 31, 2013
    (8.8 )     (2.1 )     0.6       (0.1 )     (10.4 )
December 31, 2011 to December 31, 2012
    (8.7 )     (1.7 )     1.7       (0.1 )     (8.8 )
                                         
                                         
Valuation allowances against deferred tax assets:
                                       
Successor
                                       
December 31, 2013 to December 31, 2014
    (15.8 )     (2.0 )     -       (1.9 )     (19.7 )
April 23, 2013 (Inception) to December 31, 2013)
    -       0.9       -       (16.7 )(3)     (15.8 )
                                         
                                         
Predecessor
                                       
December 31, 2012 to October 31, 2013
    (41.4 )     (3.6 )     -       -       (45.0 )
December 31, 2011 to December 31, 2012
  $ (34.5 )   $ (6.9 )   $ -     $ -     $ (41.4 )

(1)
Principally consisting of reserves for uncollectable accounts and sales returns and allowances.

(2)
Principally consisting of the opening balance sheet as a result of the MacDermid Acquisition.
(3)
Revised to reflect final purchase price allocation as presented in updates to our annual report on Form 10-K for fiscal year ended December 31, 2013, as reported in our current report on Form 8-K filed with the SEC on September 26, 2014.